Medtronic plc MDT is scheduled to report third-quarter fiscal 2025 results on Feb. 18, before the opening bell. See the Zacks Earnings Calendar to stay ahead of market-making news. In the last ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

And in the highly competitive diabetes care segment, the new MiniMed 780G insulin pump system employs AI algorithms to predict and automatically adjust insulin delivery based on real-time blood ...

Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...

Insulin allows cells to absorb and use glucose. In people with insulin resistance, the cells are unable to use insulin effectively. Insulin resistance occurs when cells in the body do not respond ...

All hybrid closed-loop systems improved time in range and time below range compared with other insulin therapies. MiniMed 780G achieved the greatest improvement in time in range of the systems.